An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes

被引:56
作者
Renaudineau, Y
Hillion, S
Saraux, A
Mageed, RA
Youinou, P
机构
[1] Brest Univ Med Sch, Immunol Lab, F-29609 Brest, France
[2] Queen Mary Sch Med, William Harvey Res Inst, London, England
关键词
D O I
10.1182/blood-2005-02-0597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
T lymphocytes and a subpopulation of B lymphocytes express the CD5 coreceptor. Its functional importance is evident from the multiple levels and developmental stages of the regulation of its expression. We here report the discovery of a novel regulatory exon upstream of the noncoding region of the CD5 gene in humans. This alternate exon 1 is designated E1B (with the conventional exon 1 renamed E1A) and was shown to regulate the expression of CD5. E1B-containing transcripts existed exclusively in B lymphocytes and encoded a protein that was truncated and retained intracellularly. As a consequence, the amount of E1A-containing transcripts was down-regulated and the membrane CD5 expression was diminished in the presence of E1B-containing transcripts. High levels of E1A transcripts were found in chronic lymphocytic leukemia, and there were no E1A transcripts in 697 pre-B cells, which have no membrane CD5. Introduction of E1B into Jurkat cells reduced their membrane expression of CD5, and sequence analysis revealed that the E1B motif is a defective human endogenous retrovirus. A balance between the 2 alternative exons 1 might be central to the regulation of membrane CD5 in human B cells, and, through CD5-associated SH2-containing phosphatase 1, to the modulation of B-cell antigen receptor-transduced signals.
引用
收藏
页码:2781 / 2789
页数:9
相关论文
共 36 条
[1]   CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity [J].
Azzam, HS ;
Grinberg, A ;
Lui, K ;
Shen, H ;
Shores, EW ;
Love, PE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2301-2311
[2]  
Berland R, 1998, J IMMUNOL, V161, P277
[3]   CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells [J].
Bikah, G ;
Carey, J ;
Ciallella, JR ;
Tarakhovsky, A ;
Bondada, S .
SCIENCE, 1996, 274 (5294) :1906-1909
[4]   The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model [J].
Caligaris-Cappio, F ;
Ghia, P .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (04) :849-+
[5]  
Caligaris-Cappio F, 2000, Rev Clin Exp Hematol, V4, P5, DOI 10.1046/j.1468-0734.2000.00001.x
[6]   Evolutionarily conserved transcription regulatory elements within the 5'-flanking region of the human CD5 gene [J].
Calvo, J ;
Sole, J ;
Simarro, M ;
Vives, J ;
Lozano, F .
TISSUE ANTIGENS, 1996, 47 (03) :257-261
[7]   PROTEIN-TYROSINE-PHOSPHATASE 1C NEGATIVELY REGULATES ANTIGEN RECEPTOR SIGNALING IN B-LYMPHOCYTES AND DETERMINES THRESHOLDS FOR NEGATIVE SELECTION [J].
CYSTER, JG ;
GOODNOW, CC .
IMMUNITY, 1995, 2 (01) :13-24
[8]  
FINDLEY HW, 1982, BLOOD, V60, P1305
[9]   TISSUE-SPECIFIC EXPRESSION OF PORPHOBILINOGEN DEAMINASE - 2 ISOENZYMES FROM A SINGLE GENE [J].
GRANDCHAMP, B ;
DEVERNEUIL, H ;
BEAUMONT, C ;
CHRETIEN, S ;
WALTER, O ;
NORDMANN, Y .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 162 (01) :105-110
[10]   CD5 maintains tolerance in anergic B cells [J].
Hippen, KL ;
Tze, LE ;
Behrens, TW .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) :883-889